Conn. Gen. Stat. § 21a-70g
Investigational drug, biological product or device for patients with terminal illnesses. Liability of manufacturer
Connecticut · General Statutes of Connecticut Chapter 417 — General Provisions. Pure Food and Drugs · Status: effective
Cite this
- Citation
- Conn. Gen. Stat. § 21a-70g, Investigational drug, biological product or device for patients with terminal illnesses. Liability of manufacturer, Connecticut, version 1 as recorded 2026-10-03, yourstate.us, https://yourstate.us/provision/2190667
- Permanent ID
ys:prov:2190667@1- SHA-256
e5888f7dc0fb5ad2bd14f4867ab36fa51c1a4b165ddb1c654cc5736dd0ebc76d
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) A manufacturer of an investigational drug, biological product or device, as defined in section 20-14q, may make available the manufacturer's investigational drug, biological product or device to a patient who is eligible under subsection (b) of section 20-14q and may (1) provide the investigational drug, biological product or device to such patient without receiving compensation, or (2) require such patient to pay the costs of, or associated with, the manufacture of the investigational drug, biological product or device.
(b) Nothing in this section shall create a cause of action against a manufacturer of an investigational drug, biological product or device that makes available such investigational drug, biological product or device to an eligible patient for any harm done to such patient resulting from the investigational drug, biological product or device.